Stockholders' Equity - Summary of Non-Vested Options (Detail) - $ / shares |
12 Months Ended | |
|---|---|---|
Nov. 30, 2020 |
Nov. 30, 2019 |
|
| Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | ||
| Non-vested at November 30, 2019, Shares | 125,234 | |
| Granted, Shares | 105,169 | |
| Vested, Shares | (137,023) | |
| Non-vested at November 30, 2020, Shares | 93,380 | 125,234 |
| Non-vested at November 30, 2019, Weighted Average Grant-Date Fair Value | $ 4.70 | |
| Granted, Weighted Average Grant-Date Fair Value | 4.66 | $ 5.02 |
| Vested, Weighted Average Grant-Date Fair Value | 4.70 | |
| Non-vested at November 30, 2020, Weighted Average Grant-Date Fair Value | $ 4.65 | $ 4.70 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Number of options vested. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|